Botox is SOOOO inferior to Dysport and Xeomin

Discussion in 'Allergan' started by Anonymous, Nov 10, 2009 at 8:48 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Just as an FYI to your kool aid rant.

    I read their PI, and the standards were higher In the Xeomin study than ours. A baseline of was the minimum for entry, but a therapeutic response was a 2 point improvement. Consequently, anyone with a baseline of 2 that wasn't still perfect, wouldn't have a 2 point response.

    We're going to need to do better than easy math and smoke and mirrors next year when they launch.

    One more competitor to take away bonus $.
     

  2. Anonymous

    Anonymous Guest

    Any copay or discount for botox
     
  3. Anonymous

    Anonymous Guest

    Are you sure you know how to read? The Xeomin PI, page 12, figure 7 is a graph of composite scores of the physicians and patients in the study. The result in the graphy show the linear downfall of a 1 grade change (GL-1) and the even faster linear decline of the 2 grade change (GL-2).

    You have so much time to rant and rave, probably because you have no job? During your time off, go back to school and take an English class. A class on grammar would be good too!
     
  4. Anonymous

    Anonymous Guest

    Wrong again. If you read the PI correctly, The graph shows the composite endpoints (physician & patient 2 point endpoint) for the 2 pivotal trials at all time points to 120 days. There is no 1 point data in the Xeomin PI unlike the Botox and Dysport trials.
     
  5. Anonymous

    Anonymous Guest

    So there isn't a 1 point linear chart they are both 2 points. Eiher way, Xeomin does NOT perform out to 120 days. 50% of Xeomin patients are lucky if it works for 30 days. Definitly not equal, absolutely not superior.